Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection

Cellular Immunology

Volumn 272, Issue 2, 2012, Pages 162-165

  He, Dengming ^a   Yan, Guohua ^a   Wang, Yuming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alanine transaminase; ELISA; Hepatitis B virus; Interleukin 12; Serum

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 12;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROCONVERSION;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERLEUKIN-12; MALE; MIDDLE AGED; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 83955165307     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.10.016     Document Type: Article

References (17)

1. Tong M.J., Hsu L.Y., Chang P.W., Blatt L.M. Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update. Journal of Gastroenterology and Hepatology 2011, 26:829-835.
2. Rizzetto M., Ciancio A. Chronic HBV-related liver disease. Molecular Aspects of Medicine 2008, 29:72-84.
3. Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infectious Diseases 2002, 2:43-50.
4. Hamza T., Barnett J.B., Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. International Journal of Molecular Sciences 2010, 11:789-806.
5. Kang T.J., Lee S.B., Chae G.T. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002, 20:56-62.
6. Trinchieri G. Function and clinical use of interleukin-12. Current Opinion in Hematology 1997, 4:59-66.
7. Nicoletti F., Di Marco R., Zaccone P., Salvaggio A., Magro G., Bendtzen K., Meroni P. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 2000, 32:728-733.
8. King I.L., Segal B.M. Cutting edge: IL-12 induces CD4(+)CD25(-) T cell activation in the presence of T regulatory cells. Journal of Immunology 2005, 175:641-645.
9. Xiong S.Q., Lin B.L., Gao X., Tang H., Wu C.Y. IL-12 promotes HBV-specific central memory CD8(+) T cell responses by PBMCs from chronic hepatitis B virus carriers. International Immunopharmacology 2007, 7:578-587.
10. Lohr H.F., Pingel S., Bochner W.O., Bernhard H., Herzog-Hauff S., Rose-John S., Galle P.R. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clinical and Experimental Immunology 2002, 130:107-114.
11. Cavanaugh V.J., Guidotti L.G., Chisari F.V. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. Journal of Virology 1997, 71:3236-3243.
12. Novelli F., Casanova J.L. The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine & Growth Factor Reviews 2004, 15:367-377.
13. Naoumov N.V., Rossol S. Studies of interleukin-12 in chronic hepatitis B virus infection. Journal of Viral Hepatitis 1997, 4:87-91.
14. Wu J.F., Wu T.C., Chen C.H., Ni Y.H., Chen H.L., Hsu H.Y., Chang M.H. Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 2010, 138:165-172.
15. Ozkan T.B., Budak F., Erdemir G., Ozgur T., Aker S. Do liver IL-12 levels predict sustained response to IFN-alpha therapy in children with chronic hepatitis B?. Journal of Interferon and Cytokine Research 2010, 30:433-438.
16. Schlaak J.F., Tully G., Lohr H.F., Gerken G., zum Buschenfelde K.H.M. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. Journal of Hepatology 1999, 30:353-358.
17. Schlaak J.F., Tully G., Lohr H.F., Gerken G., zum Buschenfelde K.H.M. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clinical and Experimental Immunology 1999, 115:508-514.